"the drug must be administered at the right time point during development," he said.
.

.
.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."
https://grassfed.us/Husman-sister-of-Heibel-from-So-Vicente